Science for a better life
  • Contact us
  • Deutsch
Global
  • [DE]
  • Search
  • Menu
  • Home
  • This is Bayer
    • This is Bayer

      Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.

      Overview
      • Overview
      • Profile and Organization
        • At a Glance
        • Our Strategy
        • Our Brand. Our Values.
        • Pharmaceuticals
        • Consumer Health
        • Crop Science
        • Animal Health
        • Business Services
        • Currenta
      • Societal Needs
        • Our Contribution to a Better Life
        • Smart Fields
        • Allergies a Common Disorder
        • For the Heart
        • Fit in Old Age
        • Defying the Weather
        • Shrinking Farmland
        • Living with Dengue
        • The Future of Agriculture and Food
      • Bayer Employees
      • Bayer Worldwide
        • Overview
        • Europe, Middle East & Africa
          • Europe, Middle East & Africa
          • German Sites
        • North America
        • Asia/Pacific
        • Latin America
        • Websites Worldwide
      • Procurement
        • Procurement at Bayer
        • Strategy
        • Sustainability in Procurement
          • Our Approach
          • Supplier Code of Conduct
          • Industry Initiatives
        • Supplier Information
          • Conditions of Purchase
          • Invoicing
          • Downloads & Links
      • Corporate Compliance
        • Policy
        • Transfers of Value to Healthcare Professionals
          • Commitment
          • Collaboration with Healthcare Professionals
          • Facts on Disclosure
          • Data Disclosure
        • CPSIA
        • Information & IT Security
      • Corporate Governance
        • Overview
        • Duties and Activities of the Board of Management
        • Supervisory Board
        • Disclosure of Managers‘ Transactions
        • Number of Women in Management Positions
        • Control
        • Corporate Compliance
        • Transparency
        • Links & Downloads
      • Political Involvement
      • History
        • Overview
        • 1863–1881
        • 1881–1914
        • 1914–1925
        • 1925–1945
        • 1945–1951
        • 1951–1974
        • 1974–1988
        • 1988–2001
        • 2001–2010
        • 2010–2017
        • 2013 – 150 Years of Bayer
        • Biographies
        • The Bayer Cross
        • The Corporate Archives
      • Board of Management
        • Members
          • Werner Baumann
          • Johannes Dietsch
          • Dr. Hartmut Klusik
          • Kemal Malik
          • Dieter Weinand
          • Heiko Schipper
          • Liam Condon
        • Offices Held at Other Companies
        • Compensation
      • Supervisory Board
        • Members
        • Committees
        • Compensation
      • Calendar
        • Current Events
        • Archive
        • Science For A Better Life Tour
      • Contact Us
  • Innovation
    • Innovation

      Bayer is an innovation company with a more than 150-year history. Our scientific successes are intended to help improve people’s lives.

      Overview
      • Overview
      • Research at Bayer
        • Overview
        • Health Care
        • Nutrition
        • Technology
      • Open Innovation
        • Leaps by Bayer
        • Bayer LifeScience iHUB
        • Bayer at Slush 2017
      • research – The Bayer Scientific Magazine
  • Products
    • Products

      With our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition.

      Overview
      • Overview
      • Product Areas
      • Chempark Management
      • Information for Patients
      • Beware of Counterfeits
        • Overview
        • Recognizing Fakes
        • Background Information
        • Fraudulent Use of Brands
        • Commitment against Counterfeits
        • News
        • Links
      • Report a Side-Effect
      • Products from A to Z
  • Sustainability
    • Sustainability

      Read more about our economic, ecological and social challenges and opportunities.

      Overview
      • Overview
      • Strategy
        • Overview
        • Latest Key Data
        • Targets and Performance Indicators
        • Development
        • UN Global Compact
      • Key Topics
        • Healthcare
        • Food Security
      • Management and Governance
        • Sustainability Management
        • Stakeholder Dialogue
        • Global Commitment to Sustainability
        • Bayer Group Regulations
          • Sustainable Development Policy
          • Corporate Compliance Policy
          • Supplier Code of Conduct
          • Responsible Marketing & Sales Group Regulation
          • Code of Conduct for Responsible Lobbying
          • Bayer Human Rights Position
          • Modern Slavery Act Statement
          • Position on Responsible Care
        • Bayer Positions
          • UN Sustainable Development Goals
          • Position on Global Product Strategy
          • Bayer Water Position
          • Bayer's Position on the Protection of Biodiversity
      • Supplier Management
      • Employees
      • Product Stewardship
        • Overview
        • Drugs & Medical Products
        • Crop Protection Products & Seeds
        • Antibiotics for Animals
      • Partnerships
      • Safety
      • Environmental Protection
      • Societal Engagement
        • Overview
        • Education and Research
          • Overview
          • School Support
          • Agricultural Education
          • Student Competitions
          • Baylabs
          • Making Science Make Sense
        • Health and Social Needs
          • Overview
          • Fight against Non-Communicable Diseases
          • Family Planning
          • Ambassadors for Contraception
          • Neglected Tropical Diseases
          • Disaster Aid
        • Bayer Scholarships
        • Bayer Clubs
        • Sports
          • Bayer and Sports
          • Successful Bayer Athletes
          • History
          • Disabled Sports
          • Paralympics 2016
          • Promotion of New Talent
          • Bayer 04 Leverkusen
        • Culture
        • Bayer Foundations
        • International Volunteering Program
          • Overview
          • China, Yunnan
          • German, Berlin
          • USA, Lubbock
          • Colombia, Bogotá
          • France, Lyon
          • Italy, Milan
          • Kenya, Chepkanga
          • Ukraine, Kharkiv
          • Taichung
      • Report
      • Ratings, Rankings and Awards
      • Straight Forward
        • Overview
        • Side Effects of Drugs
        • Safety of Crop Protection Products
        • Access to Medicine
        • Smallholder Farmers
        • Bee Health
        • Genetic Engineering
        • Standards for Clinical Studies
        • Ethics in Business Practices
        • Use of Water
        • Response to Climate Change
        • Suppliers
        • Animal Studies: Why?
  • Media
    • Media

      This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group.

      Overview
      • Overview
      • News
      • Biographies
        • Board of Management
          • Werner Baumann
          • Johannes Dietsch
          • Dr. Hartmut Klusik
          • Kemal Malik
          • Dieter Weinand
          • Heiko Schipper
          • Liam Condon
        • Supervisory Board
          • Werner Wenning
          • Oliver Zühlke
      • Speeches
      • Photos
      • TV Footage
      • Publications
        • Overview
        • Integrated Annual Reports
        • Quarterly Reports
        • Bayer Magazine
        • BEENOW Magazine
        • Farming’s Future Magazine
        • research Magazine
        • technology solutions Magazine
        • From Molecules to Medicine
        • From Molecules to Veterinary Medicines Brochure
        • Integrated Weed Management
        • Names | Figures | Facts
        • Transfers of Value to Physicians Brochure
        • Newsletter Overview
      • Videos
      • Social Media
        • Social Media Room
        • Social Media Channels
      • Apps
      • Events
        • Current
        • Archive
      • Media Contact
  • Investors
    • Investors

      We want to create value for our shareholders through innovation, growth and high earning power.

      Overview
      • Overview
      • Bayer Group
        • About Bayer
          • Key Figures
          • Profile and Organization
          • Subsidiaries
          • Acquisitions and Divestitures
          • Our Products
          • Markets and Economic Outlook
          • Research & Development
          • Bayer@Social Media
          • Brochure Names Figures Facts
        • Brand & Values
        • Strategic Alignment
          • Group Strategy
          • Strategies of the Segments
          • Value-Based Performance
        • Outlook and Targets
        • Opportunity and Risk Report
        • Corporate Governance
        • Articles of Incorporation
        • Board of Management
        • Supervisory Board
        • Sustainability and Commitment
      • Stock
        • Investors
          • Key Messages to Investors
          • New Investors
          • Institutional Investors
          • Private Investors
          • Fixed Income Investors
          • Socially Responsible Investing
        • Listing and Key Figures
          • Basic Data
          • Key Figures
          • Share Listings
          • Equity Indices
          • ADR Program
        • Share Price
          • Current Share Price
          • Charts
          • Closing Prices
        • Dividends
        • Profitability
        • Analysts
          • Analysts' Ratings
          • Consensus
        • Stockholders' Portal
        • Ownership Structure
          • Overview
          • Voting Rights Announcements
          • Archive Voting Rights Announcements
        • Stock Programs
          • Overview
          • Aspire
          • Participation Program
        • Stock History
        • Glossary
        • Archive
      • Bonds
        • Overview
        • Financial Strategy
          • Financial Management
          • Liability Mix
          • Maturity Profile
          • Net Financial Debt
          • Credit Default Swaps
        • Funding Instruments
          • Overview
          • Commercial Paper Programme
          • Syndicated Loan Facility
        • Bonds Issued
        • Rating
        • Bond News
        • Credit Analysts
        • Credit Relations
      • Reports
        • Annual Reports
          • Overview
          • Key Figures Comparison
          • Financial Position
          • Income Statement
          • Cashflow Statement
          • Segment Overview
          • Region Overview
          • Five-Year Summary
        • Quarterly Reports
        • Bayer AG Financial Statements
        • Sustainability Reports
        • Archive
      • Annual Stockholders’ Meeting 2018
        • Overview
        • Notice of the Meeting & Agenda
          • Overview
          • Item 1
          • Item 2
          • Item 3
          • Item 4
          • Item 5
        • Stockholders Countermotions and Election Proposals
        • How to Vote & Stockholders’ Portal
        • Service
          • Overview
          • Important Dates
          • Getting to the Meeting
          • Stockholders’ Hotline
          • Downloads
        • Archive
      • Events
        • Calendar
        • Live Events
          • Q1 2018 Conference Call
          • FY/Q4 2017 Conference Call
          • Bayer to Acquire Monsanto
        • Investor Conferences
        • Stockholders' Meeting
          • Overview
          • ASM 2017
          • ASM 2016
          • ASM 2015
          • ASM 2014
          • ASM 2013
          • ASM 2012
          • ASM 2011
          • ASM 2010
          • ASM 2009
          • ASM 2008
          • ASM 2007
          • ASM 2006
          • ASM 2005
          • Extraordinary ASM 2004
          • ASM 2004
          • ASM 2003
          • ASM 2002
        • Press Conferences
        • Roadshows
        • Other Presentations
        • Archive
          • 2017
            • Overview
            • Q3 2017 Conference Call
            • Xarelto COMPASS Data at ESC Congress 2017
            • Q2 2017 Conference Call
            • Q1 2017 Conference Call
            • Meet Management 2017 in London
            • FY/Q4 2016 Conference Call
          • 2016
            • Overview
            • Q3 2016 Conference Call
            • Meet Management 2016
            • Bayer to Acquire Monsanto
            • Q2 2016 Conference Call
            • Bayer Offers to Acquire Monsanto
            • Q1 2016 Conference Call
            • FY/Q4 2015 Conference Call
          • 2015
            • Overview
            • Q3 2015 Conference Call
            • Finerenone Data at ESC Congress 2015
            • Q2 2015 Conference Call
            • Meet Management 2015 NY
            • Q1 2015 Conference Call
            • Meet Management 2015 in Berlin
            • FY/Q4 2014 Conference Call
          • 2014
            • Overview
            • Q3 2014 Conference Call
            • Meet Management 2014 LDN
            • Conference Call 2014-09-18 Planned Demerger MaterialScience
            • Q2 2014 Conference Call
            • Meet Management 2014 NY
            • Conference Call 2014-05-06 Acquisition CC Business Merck
            • Q1 2014 Conference Call
            • Meet Management 2014 LEV
            • FY/Q4 2013 Conference Call
          • 2013
            • Overview
            • Q3 2013 Conference Call
            • Meet Management 2013 LDN
            • Q2 2013 Conference Call
            • Meet Management 2013 NY
            • Q1 2013 Conference Call
            • Meet Management 2013 LEV
            • FY/Q4 2012 Conference Call
          • 2012
            • Overview
            • Meet Management in Tokyo
            • Q3 2012 Conference Call
            • Riociguat Data at CHEST 2012
            • Q2 2012 Conference Call
            • Meet Management 2012 NY
            • Q1 2012 Conference Call
            • Conference Call ACC 2012
            • Meet Management 2012 LEV
            • FY/Q4 2011 Conference Call
            • Regorafenib Data at ASCO-GI
          • 2011
            • Overview
            • China Investor Conference
            • Rivaroxaban Data at AHA 2011
            • Q3 2011 Conference Call
            • Q2 2011 Conference Call
            • Q1 2011 Conference Call
            • Rivaroxaban Data at ACC 2011
            • FY/Q4 2010 Conference Call
          • 2010
            • Overview
            • Q3 2010 Conference Call
            • Rivaroxaban Data at ESC 2010
            • Q2 2010 Conference Call
            • Q1 2010 Conference Call
            • FY/Q4 2009 Conference Call
          • 2009
            • Overview
            • Rivaroxaban Data at ASH 2009
            • Q3 2009 Conference Call
            • Q2 2009 Conference Call
            • Riociguat Data at ATS 2009
            • Q1 2009 Conference Call
            • FY/Q4 2008 Conference Call
          • 2008
            • Overview
            • Rivaroxaban Data at AHA 2008
            • Q3 2008 Conference Call
            • Q2 2008 Conference Call
            • Rivaroxaban Data at EFORT 2008
            • Q1 2008 Conference Call
            • FY/Q4 2007 Conference Call
          • 2007
            • Overview
            • Rivaroxaban Data at ASH 2007
            • Q3 2007 Conference Call
            • Q2 2007 Conference Call
            • HealthCare Investor Day 2007
            • Nexavar Data at ASCO 2007
            • Q1 2007 Conference Call
            • FY/Q4 2006 Conference Call
          • 2006
            • Overview
            • Nexavar Melanoma Conference Call
            • Q3 2006 Conference Call
            • Rivaroxaban Conference Call
            • Q2 2006 Conference Call
            • Q1 2006 Conference Call
            • FY/Q4 2005 Conference Call
          • 2005
            • Overview
            • Bayer R&D Investor Day 2005
            • Q3 2005 Conference Call
            • CSFB Chemical Hybrid Tour 2005
            • CropScience Analyst & Investor Days
            • Q2 2005 Conference Call
            • Data on BAY 59-7939 at ISTH 2005
            • Sorafenib Data at ASCO 2005
            • Q1 2005 Conference Call
            • Spring Investor Conference 2005
          • 2004
            • Overview
            • Fall Investor Conference 2004
            • BAY 43-9006 Data at EORTC Symposium
            • CSFB Field Trip on September 22, 2004
            • 1H 2004 Investor Conference
            • BAY 43-9006 Data at ASCO 2004
            • Q1 2004 Conference Call
            • Spring Investor Conference 2004
          • 2003
            • Overview
            • CSFB Field Trip on November 21, 2003
            • Fall Investor Conference 2003
            • Conference Call on Ad-hoc message Nov 7, 2003
            • Q1 2003 Conference Call
            • Spring Investor Conference 2003
          • 2002
            • Overview
            • Spring Investor Conference 2002
            • Half Year Investor Conference 2002
            • Spring Investor Conference 2002
            • Spring Financial News Conference 2002
          • 2001
            • Overview
            • Fall Investor Conference 2001
            • Investor Conference Call on the Acquisition of Aventis CropScience
            • News Conference Call: Acquisition of Aventis CropScience
            • Half Year Investor Conference 2001
            • Spring Investor Conference 2001
            • Spring Financial News Conference 2001
          • 2000
            • Overview
            • Fall Investor Conference 2000
            • Investor Conference New York
            • Spring Investor Conference 2000
            • Spring Press Conference 2000
          • 1999
      • Inside Information
        • Latest Inside Information
        • Archive Overview
        • Inside Information 2017
        • Ad-hoc 2016
        • Ad-hoc 2015
        • Ad-hoc 2014
        • Ad-hoc 2013
        • Ad-hoc 2012
        • Ad-hoc 2011
        • Ad-hoc 2010
        • Ad-hoc 2009
        • Ad-hoc 2008
        • Ad-hoc 2007
        • Ad-hoc 2006
        • Ad-hoc 2005
        • Ad-hoc 2004
        • Ad-hoc 2003
        • Ad-hoc 2002
        • Ad-hoc 2001
        • Ad-hoc 2000
        • Ad-hoc 1999
        • Ad-hoc 1998
      • News
        • Investor News
        • Press
        • Archive
          • Overview
          • Investor News 2017
          • Investor News 2016
          • Investor News 2015
          • Investor News 2014
          • Investor News 2013
          • Investor News 2012
          • Investor News 2011
          • Investor News 2010
          • Investor News 2009
          • Investor News 2008
          • Investor News 2007
          • Investor News 2006
          • Investor News 2005
          • Investor News 2004
          • Investor News 2003
          • Investor News 2002
          • Investor News 2001
          • Investor News 2000
      • Handouts
        • Investor Handout
        • Investor Factsheet
        • Presentations
        • Archive Investor Handouts
        • Archive Presentations
      • Downloads
        • Current Downloads
        • 2013-2017
          • 2017
          • 2016
          • 2015
          • 2014
          • 2013
        • 2008-2012
          • 2012
          • 2011
          • 2010
          • 2009
          • 2008
        • 2003-2007
          • 2007
          • 2006
          • 2005
          • 2004
          • 2003
        • 1998-2002
          • 2002
          • 2001
          • 2000
          • 1999
          • 1998
      • Service
        • Quicklinks
        • Contact IR Team
        • Order Publications
        • Newsletter
        • RSS Newsfeeds
          • RSS Help Page
        • Podcasts
        • Mobile Services
        • Collected Downloads
        • New on this site
        • FAQs
        • Investor Factsheet
  • Career
    • Career

      Looking for a job in an innovative company? Learn more about Bayer and the opportunities available.

      Overview
      • Overview
      • Why Bayer
        • Overview
        • Innovation & Solutions
        • Development & Teamwork
        • Better Life & Challenges
        • Reputation & Impact
        • Benefits & Rewards
        • Values & Stories
          • Overview
          • David against Goliath
          • Singapore's Supertrees
          • Sky-high vegetables
          • Bringing light into darkness
          • Rice for a hungry planet
          • Bridging Distances
          • Healthy for Life
          • Work and Life in balance
          • The Secret of the Bridge
      • Working at Bayer
        • Overview
        • Meet our employees
        • Students
        • Graduates
          • Overview
          • International Future Leadership Program for Production - Engineers, Pharmacists, Natural Scientists
          • International Trainee Program for Financial Management
          • International HR Trainee Program
          • Global Trainee Program for Supply Chain Management
          • International Procurement Management Trainee Program
        • Professionals
        • Bayer Career Worldwide
      • Marketing
      • How to join us
        • Overview
        • How to apply
        • The Interview
        • Check status
      • Contact us
  • Magazine
  • Search
  • Kontakt
  • Home
  • Investors
  • Events
  • Archive
  • 2010
  • FY/Q4 2009 Conference Call
  • Overview
  • Bayer Group
    • About Bayer
      • Key Figures
      • Profile and Organization
      • Subsidiaries
      • Acquisitions and Divestitures
      • Our Products
      • Markets and Economic Outlook
      • Research & Development
      • Bayer@Social Media
      • Brochure Names Figures Facts
    • Brand & Values
    • Strategic Alignment
      • Group Strategy
      • Strategies of the Segments
      • Value-Based Performance
    • Outlook and Targets
    • Opportunity and Risk Report
    • Corporate Governance
    • Articles of Incorporation
    • Board of Management
    • Supervisory Board
    • Sustainability and Commitment
  • Stock
    • Investors
      • Key Messages to Investors
      • New Investors
      • Institutional Investors
      • Private Investors
      • Fixed Income Investors
      • Socially Responsible Investing
    • Listing and Key Figures
      • Basic Data
      • Key Figures
      • Share Listings
      • Equity Indices
      • ADR Program
    • Share Price
      • Current Share Price
      • Charts
      • Closing Prices
    • Dividends
    • Profitability
    • Analysts
      • Analysts' Ratings
      • Consensus
    • Stockholders' Portal
    • Ownership Structure
      • Overview
      • Voting Rights Announcements
      • Archive Voting Rights Announcements
    • Stock Programs
      • Overview
      • Aspire
      • Participation Program
    • Stock History
    • Glossary
    • Archive
  • Bonds
    • Overview
    • Financial Strategy
      • Financial Management
      • Liability Mix
      • Maturity Profile
      • Net Financial Debt
      • Credit Default Swaps
    • Funding Instruments
      • Overview
      • Commercial Paper Programme
      • Syndicated Loan Facility
    • Bonds Issued
    • Rating
    • Bond News
    • Credit Analysts
    • Credit Relations
  • Reports
    • Annual Reports
      • Overview
      • Key Figures Comparison
      • Financial Position
      • Income Statement
      • Cashflow Statement
      • Segment Overview
      • Region Overview
      • Five-Year Summary
    • Quarterly Reports
    • Bayer AG Financial Statements
    • Sustainability Reports
    • Archive
  • Annual Stockholders’ Meeting 2018
    • Overview
    • Notice of the Meeting & Agenda
      • Overview
      • Item 1
      • Item 2
      • Item 3
      • Item 4
      • Item 5
    • Stockholder Counter-Motions
    • How to Vote & Stockholders Portal
    • Service
      • Overview
      • Important Dates
      • Getting to the Meeting
      • Stockholders Hotline
      • Downloads
    • Archive
  • Events
    • Calendar
    • Live Events
      • Q1 2018 Conference Call
      • FY/Q4 2017 Conference Call
      • Bayer to Acquire Monsanto
    • Investor Conferences
    • Stockholders' Meeting
      • Overview
      • ASM 2017
      • ASM 2016
      • ASM 2015
      • ASM 2014
      • ASM 2013
      • ASM 2012
      • ASM 2011
      • ASM 2010
      • ASM 2009
      • ASM 2008
      • ASM 2007
      • ASM 2006
      • ASM 2005
      • Extraordinary ASM 2004
      • ASM 2004
      • ASM 2003
      • ASM 2002
    • Press Conferences
    • Roadshows
    • Other Presentations
    • Archive
      • 2017
        • Overview
        • Q3 2017 Conference Call
        • Xarelto COMPASS Data at ESC Congress 2017
        • Q2 2017 Conference Call
        • Q1 2017 Conference Call
        • Meet Management 2017 in London
        • FY/Q4 2016 Conference Call
      • 2016
        • Overview
        • Q3 2016 Conference Call
        • Meet Management 2016
        • Bayer to Acquire Monsanto
        • Q2 2016 Conference Call
        • Bayer Offers to Acquire Monsanto
        • Q1 2016 Conference Call
        • FY/Q4 2015 Conference Call
      • 2015
        • Overview
        • Q3 2015 Conference Call
        • Finerenone Data at ESC Congress 2015
        • Q2 2015 Conference Call
        • Meet Management 2015 NY
        • Q1 2015 Conference Call
        • Meet Management 2015 in Berlin
        • FY/Q4 2014 Conference Call
      • 2014
        • Overview
        • Q3 2014 Conference Call
        • Meet Management 2014 LDN
        • Conference Call 2014-09-18 Planned Demerger MaterialScience
        • Q2 2014 Conference Call
        • Meet Management 2014 NY
        • Conference Call 2014-05-06 Acquisition CC Business Merck
        • Q1 2014 Conference Call
        • Meet Management 2014 LEV
        • FY/Q4 2013 Conference Call
      • 2013
        • Overview
        • Q3 2013 Conference Call
        • Meet Management 2013 LDN
        • Q2 2013 Conference Call
        • Meet Management 2013 NY
        • Q1 2013 Conference Call
        • Meet Management 2013 LEV
        • FY/Q4 2012 Conference Call
      • 2012
        • Overview
        • Meet Management in Tokyo
        • Q3 2012 Conference Call
        • Riociguat Data at CHEST 2012
        • Q2 2012 Conference Call
        • Meet Management 2012 NY
        • Q1 2012 Conference Call
        • Conference Call ACC 2012
        • Meet Management 2012 LEV
        • FY/Q4 2011 Conference Call
        • Regorafenib Data at ASCO-GI
      • 2011
        • Overview
        • China Investor Conference
        • Rivaroxaban Data at AHA 2011
        • Q3 2011 Conference Call
        • Q2 2011 Conference Call
        • Q1 2011 Conference Call
        • Rivaroxaban Data at ACC 2011
        • FY/Q4 2010 Conference Call
      • 2010
        • Overview
        • Q3 2010 Conference Call
        • Rivaroxaban Data at ESC 2010
        • Q2 2010 Conference Call
        • Q1 2010 Conference Call
        • FY/Q4 2009 Conference Call
      • 2009
        • Overview
        • Rivaroxaban Data at ASH 2009
        • Q3 2009 Conference Call
        • Q2 2009 Conference Call
        • Riociguat Data at ATS 2009
        • Q1 2009 Conference Call
        • FY/Q4 2008 Conference Call
      • 2008
        • Overview
        • Rivaroxaban Data at AHA 2008
        • Q3 2008 Conference Call
        • Q2 2008 Conference Call
        • Rivaroxaban Data at EFORT 2008
        • Q1 2008 Conference Call
        • FY/Q4 2007 Conference Call
      • 2007
        • Overview
        • Rivaroxaban Data at ASH 2007
        • Q3 2007 Conference Call
        • Q2 2007 Conference Call
        • HealthCare Investor Day 2007
        • Nexavar Data at ASCO 2007
        • Q1 2007 Conference Call
        • FY/Q4 2006 Conference Call
      • 2006
        • Overview
        • Nexavar Melanoma Conference Call
        • Q3 2006 Conference Call
        • Rivaroxaban Conference Call
        • Q2 2006 Conference Call
        • Q1 2006 Conference Call
        • FY/Q4 2005 Conference Call
      • 2005
        • Overview
        • Bayer R&D Investor Day 2005
        • Q3 2005 Conference Call
        • CSFB Chemical Hybrid Tour 2005
        • CropScience Analyst & Investor Days
        • Q2 2005 Conference Call
        • Data on BAY 59-7939 at ISTH 2005
        • Sorafenib Data at ASCO 2005
        • Q1 2005 Conference Call
        • Spring Investor Conference 2005
      • 2004
        • Overview
        • Fall Investor Conference 2004
        • BAY 43-9006 Data at EORTC Symposium
        • CSFB Field Trip on September 22, 2004
        • 1H 2004 Investor Conference
        • BAY 43-9006 Data at ASCO 2004
        • Q1 2004 Conference Call
        • Spring Investor Conference 2004
      • 2003
        • Overview
        • CSFB Field Trip on November 21, 2003
        • Fall Investor Conference 2003
        • Conference Call on Ad-hoc message Nov 7, 2003
        • Q1 2003 Conference Call
        • Spring Investor Conference 2003
      • 2002
        • Overview
        • Spring Investor Conference 2002
        • Half Year Investor Conference 2002
        • Spring Investor Conference 2002
        • Spring Financial News Conference 2002
      • 2001
        • Overview
        • Fall Investor Conference 2001
        • Investor Conference Call on the Acquisition of Aventis CropScience
        • News Conference Call: Acquisition of Aventis CropScience
        • Half Year Investor Conference 2001
        • Spring Investor Conference 2001
        • Spring Financial News Conference 2001
      • 2000
        • Overview
        • Fall Investor Conference 2000
        • Investor Conference New York
        • Spring Investor Conference 2000
        • Spring Press Conference 2000
      • 1999
  • Inside Information
    • Latest Inside Information
    • Archive Overview
    • Inside Information 2017
    • Ad-hoc 2016
    • Ad-hoc 2015
    • Ad-hoc 2014
    • Ad-hoc 2013
    • Ad-hoc 2012
    • Ad-hoc 2011
    • Ad-hoc 2010
    • Ad-hoc 2009
    • Ad-hoc 2008
    • Ad-hoc 2007
    • Ad-hoc 2006
    • Ad-hoc 2005
    • Ad-hoc 2004
    • Ad-hoc 2003
    • Ad-hoc 2002
    • Ad-hoc 2001
    • Ad-hoc 2000
    • Ad-hoc 1999
    • Ad-hoc 1998
  • News
    • Investor News
    • Press
    • Archive
      • Overview
      • Investor News 2017
      • Investor News 2016
      • Investor News 2015
      • Investor News 2014
      • Investor News 2013
      • Investor News 2012
      • Investor News 2011
      • Investor News 2010
      • Investor News 2009
      • Investor News 2008
      • Investor News 2007
      • Investor News 2006
      • Investor News 2005
      • Investor News 2004
      • Investor News 2003
      • Investor News 2002
      • Investor News 2001
      • Investor News 2000
  • Handouts
    • Investor Handout
    • Investor Factsheet
    • Presentations
    • Archive Investor Handouts
    • Archive Presentations
  • Downloads
    • Current Downloads
    • 2013-2017
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
    • 2008-2012
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
    • 2003-2007
      • 2007
      • 2006
      • 2005
      • 2004
      • 2003
    • 1998-2002
      • 2002
      • 2001
      • 2000
      • 1999
      • 1998
  • Service
    • Quicklinks
    • Contact IR Team
    • Order Publications
    • Newsletter
    • RSS Newsfeeds
      • RSS Help Page
    • Podcasts
    • Mobile Services
    • Collected Downloads
    • New on this site
    • FAQs
    • Investor Factsheet

FY/Q4 2009 Investor Conference Call

Friday, February 26, 2010
Start at approx. 4:00 p.m. CET (3:00 p.m. GMT)

Investor News February 26, 2010
2009: operationally one of the strongest years - optimism for the future

Bayer successful in a difficult environment

Group sales EUR 31,168 million (minus 5.3 percent) / EBITDA before special items EUR 6,472 million (minus 6.6 percent) / Net income EUR 1,359 million (minus 20.9 percent) / Net cash flow significantly improved to EUR 5,375 million (plus 49 percent) / Net financial debt reduced by EUR 4.5 billion to EUR 9.7 billion / Core earnings per share expected to improve by about 10 percent in 2010 more

Werner Wenning
CEO of Bayer AG

Klaus Kühn
CFO of Bayer AG

MP3 audio recording (presentation and discussion)

Presentation charts
Download PDF collect (271 KB)
Q4 2009 Analyst and Investor BriefingDownload PDF collect (74 KB)

Services

Last updated: January 07, 2014

Our Business

  • Pharmaceuticals
  • Consumer Health
  • Crop Science
  • Animal Health
  • Our Products
  • Bayer Worldwide

Magazines & Reports

  • Bayer Magazine
  • research Magazine
  • Annual Report
  • Quarterly Report
  • More Publications

Stay Tuned

  • Job Postings
  • Latest News
  • Newsletter
  • Bayer Share Price

Get in Touch

Do you have any queries or comments about our website, our products or any of our services?

Contact us

Follow Us

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • Instagram
  • RSS
Top
Copyright © Bayer AG
Sitemap
  • Conditions of Use
  • Privacy Statement
  • Imprint